Clene Inc.
NASDAQ:CLNN
Clene Inc.
NASDAQ:CLNN
Price:
5.73
USD
1.06%
Market Closed
Market Cap:
$62.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Clene Inc.
NASDAQ:CLNN
|
US |
|
Melexis NV
OTC:MLXSF
|
BE |
|
Bajaj Finance Ltd
NSE:BAJFINANCE
|
IN |
|
Radius Global Infrastructure Inc
F:R13
|
US |
|
Imeik Technology Development Co Ltd
SZSE:300896
|
CN |
|
B
|
Beijing Tricolor Technology Co Ltd
SSE:603516
|
CN |
|
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
|
CN |
|
Jiangsu Xiehe Electronic Co Ltd
SSE:605258
|
CN |
|
Gildan Activewear Inc
TSX:GIL
|
CA |
|
Capita PLC
LSE:CPI
|
UK |
|
Mandarake Inc
TSE:2652
|
JP |
|
A
|
Asia Pacific Investama Tbk PT
IDX:MYTX
|
ID |
|
A
|
Amway (Malaysia) Holdings Bhd
KLSE:AMWAY
|
MY |
|
C
|
CTI Biopharma Corp
F:CEPS
|
US |
Relative Value
The Relative Value of one
CLNN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 5.73 USD,
Clene Inc.
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CLNN Relative Value
HIDDEN
Multiples Across Competitors
CLNN Competitors Multiples
Clene Inc. Competitors
Clene Inc. Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Clene Inc.
NASDAQ:CLNN
|
62.2m USD | 310.9 | -2.4 | -3.3 | -3.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 5.9 | 86.7 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 28.8 | 21.7 | 22.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.5 | 17.4 | 12.8 | 14.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36B EUR | 10.1 | 32.5 | 35 | 35.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
